Perthera,
Looking Forward for
Hospitals, Patients, and Investors

If you are interested in learning more about Perthera, or for financial or investment inquiries, please contact us at +1 (703) 286-0780 or by clicking on the link below.

Investor Relations

Perthera’s Mission

Improving patient outcomes through A.I. and data-driven cancer therapy recommendations for any patient anywhere

Perthera is a privately held corporation with an experienced international leadership and an advisory board that includes key thought leaders, researchers, and practitioners in artificial intelligence and precision medicine.

Perthera is the leading Therapeutic Intelligence Company™ advancing precision medicine through our Perthera Report™, which precisely matches cancer patients with multiple therapeutic options ranked by highest probability of best outcome.

With the Perthera Report:

  • 73% of patients received more therapeutic options than provided by testing labs
  • 75% of these additional therapeutic options were clinical trials

Our Investors

Our Board of Directors

team member
Dendy Young

Chairman of the Board

team member
Neal Koller

President and CEO

team member
Neil Callahan

Board Member

team member
Chip Petricoin, Ph.D.

Chief Science Officer

team member
Rob Walker

Board Observer